UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
NetEase
NTES
|
+$383M |
| 2 |
AbbVie
ABBV
|
+$262M |
| 3 |
VMW
VMware, Inc
VMW
|
+$183M |
| 4 |
Aptiv
APTV
|
+$175M |
| 5 |
T-Mobile US
TMUS
|
+$170M |
Top Sells
| 1 |
Alibaba
BABA
|
+$591M |
| 2 |
Microsoft
MSFT
|
+$567M |
| 3 |
Apple
AAPL
|
+$464M |
| 4 |
Amazon
AMZN
|
+$268M |
| 5 |
Abbott
ABT
|
+$266M |
Sector Composition
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.53% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENLC
2051
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $540K | ﹤0.01% |
221,108
+5,888
| +3% | +$14.4K |
|
|
CLVS
2052
DELISTED
Clovis Oncology, Inc.
CLVS
| $538K | ﹤0.01% |
+79,755
| New | +$538K |
|
|
CCF
2053
DELISTED
Chase Corporation
CCF
| $538K | ﹤0.01% |
5,247
+2,528
| +93% | +$259K |
|
2054
Vericel Corp
VCEL
$1.58B
| $537K | ﹤0.01% |
38,884
-10,637
| -21% | -$147K |
|
|
PFC
2055
DELISTED
Premier Financial Corp. Common Stock
PFC
| $537K | ﹤0.01% |
30,379
+4,252
| +16% | +$75.1K |
|
2056
LeMaitre Vascular
LMAT
$2.1B
| $535K | ﹤0.01% |
20,252
+9,977
| +97% | +$263K |
|
2057
Guess, Inc.
GES
$868M
| $530K | ﹤0.01% |
54,856
-7,499
| -12% | -$72.5K |
|
|
AGEN
2058
Agenus
AGEN
$154M
| $530K | ﹤0.01% |
6,876
-3,206
| -32% | -$247K |
|
2059
Assembly Biosciences
ASMB
$171M
| $530K | ﹤0.01% |
1,894
+958
| +102% | +$268K |
|
2060
Chord Energy
CHRD
$6.1B
| $529K | ﹤0.01% |
705,411
-1,155,063
| -62% | -$866K |
|
2061
Trustco Bank Corp NY
TRST
$744M
| $529K | ﹤0.01% |
16,699
| – | – |
|
2062
Owens & Minor
OMI
$423M
| $526K | ﹤0.01% |
69,092
-1,155
| -2% | -$8.8K |
|
2063
BGC Group
BGC
$4.76B
| $526K | ﹤0.01% |
192,094
-124,452
| -39% | -$341K |
|
2064
Kforce
KFRC
$550M
| $526K | ﹤0.01% |
17,994
+7,424
| +70% | +$217K |
|
2065
IMAX
IMAX
$1.67B
| $526K | ﹤0.01% |
46,913
-1,921
| -4% | -$21.5K |
|
2066
National Beverage
FIZZ
$3.68B
| $525K | ﹤0.01% |
17,208
+7,432
| +76% | +$227K |
|
|
GOOD
2067
Gladstone Commercial Corp
GOOD
$598M
| $524K | ﹤0.01% |
27,964
+1,131
| +4% | +$21.2K |
|
2068
Garrett Motion
GTX
$2.66B
| $523K | ﹤0.01% |
94,399
+18,945
| +25% | +$105K |
|
|
CIO
2069
City Office REIT
CIO
$280M
| $523K | ﹤0.01% |
51,952
+11,895
| +30% | +$120K |
|
2070
E.W. Scripps
SSP
$246M
| $521K | ﹤0.01% |
59,486
-1,736
| -3% | -$15.2K |
|
2071
Viking Therapeutics
VKTX
$2.91B
| $520K | ﹤0.01% |
72,140
-14,523
| -17% | -$105K |
|
2072
Geron
GERN
$823M
| $520K | ﹤0.01% |
238,349
+160,881
| +208% | +$351K |
|
2073
Arcturus Therapeutics
ARCT
$489M
| $519K | ﹤0.01% |
+11,100
| New | +$519K |
|
2074
RE/MAX Holdings
RMAX
$187M
| $518K | ﹤0.01% |
+16,484
| New | +$518K |
|
2075
Calix
CALX
$4.11B
| $517K | ﹤0.01% |
+34,723
| New | +$517K |
|